Please login to the form below

Not currently logged in
Email:
Password:

Stallergenes appoints Christian Chavy CEO

He will replace Roberto Gradnik at the end of this month

Christian Chavy has been appointed CEO of French biopharmaceutical company Stallergenes and will take over from Roberto Gradnik at the end of this month.  

Chavy has worked for the ARES Life Science healthcare investment fund since 2010 and prior to that he served as president of global operations for Actelion Pharmaceuticals.  

Before joining Actelion he was vice president of Serono's reproductive medicine strategic unit and chairman of the company's French subsidiary.

Stallergenes said Chavy's appointment would enable it to “pursue its strategy” and to its work in promising immunotherapy markets – the US in particular.  

Meanwhile Gradnick, who joined Stallergenes in October 2011 as deputy CEO before taking up the post of CEO three months later, will provide consultancy services to the board of directors during a four-month transitional period.

7th March 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

It’s all about patient outcomes… right?
Lessons from history: a design thinking perspective...
Emma Walmsley 2
30 Women Leaders in UK Healthcare (part 3)
Continuing our special feature on Women Leaders in UK Healthcare...
Louise Houson
30 Women Leaders in UK Healthcare
The enormous challenges facing UK healthcare mean it needs great leaders. PME’s Group Editor Andrew McConaghie introduces 30 outstanding innovators and trailblazers helping to shape the future...

Infographics